Pura Vida Investments’s Boston Scientific BSX Stock Holding History

Pura Vida Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-48,635	Closed	-$1.88M	–	207
2022 Q3	$1.88M	Buy	+48,635	New	+$1.95M	0.11%	135
2020 Q3	–	Sell	-183,500	Closed	-$6.44M	–	157
2020 Q2	$6.44M	Buy	183,500 +58,500	+47%	+$2.11M	0.62%	40
2020 Q1	$4.08M	Buy	+125,000	New	+$4.88M	0.48%	46
2019 Q3	–	Sell	-235,000	Closed	-$10.1M	–	102
2019 Q2	$10.1M	Buy	235,000 +25,000	+12%	+$962K	1.53%	18
2019 Q1	$8.06M	Buy	210,000 +186,965	+812%	+$7.14M	1.15%	23
2018 Q4	$814K	Sell	23,035 -229,890	-91%	-$8.34M	0.16%	58
2018 Q3	$9.74M	Buy	252,925 +227,925	+912%	+$7.96M	2.05%	8
2018 Q2	$818K	Sell	25,000 -62,500	-71%	-$1.89M	0.33%	72
2018 Q1	$2.39M	Sell	87,500 -142,500	-62%	-$3.87M	1.41%	25
2017 Q4	$5.7M	Sell	230,000 -160,000	-41%	-$4.41M	2.39%	13
2017 Q3	$11.4M	Sell	390,000 -30,546	-7%	-$844K	3.33%	3
2017 Q2	$11.7M	Buy	420,546 +55,546	+15%	+$1.47M	4.63%	2
2017 Q1	$9.08M	Sell	365,000 -15,000	-4%	-$365K	2.68%	6
2016 Q4	$8.22M	Buy	380,000 +180,000	+90%	+$3.93M	3.01%	9
2016 Q3	$4.76M	Buy	200,000 +15,000	+8%	+$358K	1.45%	25
2016 Q2	$4.32M	Sell	185,000 -115,000	-38%	-$2.49M	1.84%	21
2016 Q1	$5.64M	Sell	300,000 -35,000	-10%	-$615K	2.57%	9
2015 Q4	$6.18M	Sell	335,000 -80,000	-19%	-$1.43M	2.61%	8
2015 Q3	$6.81M	Buy	415,000 +180,000	+77%	+$3.08M	3.89%	5
2015 Q2	$4.08M	Sell	235,000 -290,000	-55%	-$5.18M	2.09%	13
2015 Q1	$9.32M	Sell	525,000 -75,000	-13%	-$1.19M	4.81%	3
2014 Q4	$7.95M	Buy	+600,000	New	+$7.67M	2.92%	6

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pura Vida Investments's BSX Position: Q4 2022 in Review

Pura Vida Investments sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 48,635 shares — an estimated $1.88M sold.

Pura Vida Investments first reported a position in BSX in Q4 2014 and held it in 22 quarters. The position peaked at $11.7M in Q2 2017. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

Pura Vida Investments reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 48,635 Boston Scientific shares in Q4 2022, an estimated $1.88M.
Pura Vida Investments first reported a position in Boston Scientific in Q4 2014 and held it in 22 quarters.
Pura Vida Investments's Boston Scientific position peaked at $11.7M in Q2 2017.
928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.